Helen M Parsons1, Linda C Harlan2, Susanne Schmidt1, Theresa H M Keegan3, Charles F Lynch4, Erin E Kent2, Xiao-Cheng Wu5, Stephen M Schwartz6, Roland L Chu7, Gretchen Keel8, Ashley Wilder Smith2. 1. Department of Epidemiology and Biostatistics, The University of Texas Health Science Center , San Antonio, Texas. 2. Applied Research Program, National Cancer Institute , Bethesda, Maryland. 3. The Cancer Prevention Institute of California , Fremont, California. 4. Department of Epidemiology, University of Iowa , Iowa City, Iowa. 5. Louisiana Tumor Registry, Louisiana State University Health Sciences Center , New Orleans, Louisiana. 6. Epidemiology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center , Seattle, Washington. 7. Department of Pediatrics, Wayne State University , Detroit, Michigan. 8. Information Management Services , Calverton, Maryland.
Abstract
PURPOSE: Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancer patients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited. METHODS: Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests. RESULTS: Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73% were treated at a cancer center compared with 56% of patients with germ cell cancer (p < 0.01), while ALL (85%) and sarcoma (87%) patients were more likely to be treated in hospitals with residency programs (p < 0.01). CONCLUSIONS: Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patient cancer type and age at diagnosis.
PURPOSE: Physicians play a critical role in delivering effective treatment and enabling successful transition to survivorship among adolescent and young adult (AYA) cancerpatients. However, with no AYA cancer medical specialty, information on where and by whom AYAs with cancer are treated is limited. METHODS: Using the National Cancer Institute's population-based AYA HOPE Study, 464 AYAs aged 15-39 at diagnosis treated by 903 physicians were identified. Differences in physician and hospital characteristics were examined by age at diagnosis and cancer type (germ cell cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, acute lymphocytic leukemia [ALL], and sarcoma) using chi-square tests. RESULTS: Treating physicians were predominately 51-64 years old, male, United States-trained in non-pediatric specialties, and in group practices within large metropolitan areas. Older patients were less often treated by pediatric physicians (p < 0.01) and more likely to be treated by United States-trained physicians without research/teaching responsibilities and in hospitals without residency programs (p < 0.05). The majority of the few pediatricians (n = 44) treated ALL patients. Physicians with research/teaching responsibilities and those based in medical schools were more likely to treat patients with ALL and sarcoma compared with other cancer types (p < 0.01). Of HL patients, 73% were treated at a cancer center compared with 56% of patients with germ cell cancer (p < 0.01), while ALL (85%) and sarcoma (87%) patients were more likely to be treated in hospitals with residency programs (p < 0.01). CONCLUSIONS: Most AYAs with cancer were treated by non-pediatric physicians in community settings, although physician characteristics varied significantly by patientcancer type and age at diagnosis.
Entities:
Keywords:
AYA HOPE Study; physicians; place of care; treatment
Authors: Laura-Mae Baldwin; Walter Adamache; Carrie N Klabunde; Kevin Kenward; Celia Dahlman; Joan L Warren Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Megan E Pailler; Lynda K Beaupin; Erin Brewer-Spritzer; Pei C Grant; Rachel M Depner; Kathryn Levy; Kelly E Tenzek Journal: J Adolesc Young Adult Oncol Date: 2020-04-07 Impact factor: 2.223
Authors: Anne C Kirchhoff; Brynn Fowler; Echo L Warner; Samantha T Pannier; Douglas Fair; Holly Spraker-Perlman; Jeff Yancey; Brad Bott; Carolyn Reynolds; R Lor Randall Journal: J Adolesc Young Adult Oncol Date: 2017-06-12 Impact factor: 2.223
Authors: Andrea C Betts; Caitlin C Murphy; L Aubree Shay; Bijal A Balasubramanian; Christine Markham; Marlyn Allicock Journal: J Cancer Surviv Date: 2022-01-08 Impact factor: 4.442
Authors: Ashley Wilder Smith; Theresa Keegan; Ann Hamilton; Charles Lynch; Xiao-Cheng Wu; Stephen M Schwartz; Ikuko Kato; Rosemary Cress; Linda Harlan Journal: Pediatr Blood Cancer Date: 2018-10-07 Impact factor: 3.167